specialized consultants to provide a feasibility review and develop a business plan for development of a viral vector manufacturing facility in a current cell manufacturing facility
HEALTH AND HUMAN SERVICES, DEPARTMENT OF
Who can apply
No Set aside used. NONE
About this opportunity
Notice Number: NOI-CC-26-002367 Description: This is a notice of intent, not a request for a quotation. A solicitation document will not be issued and quotations will not be requested. This procurement is for specialized consultants to provide a feasibility review and develop a business plan for development of a viral vector manufacturing facility in a current cell manufacturing facility. The manufacturing will encompass retroviral/lentiviral vectors, AAV and transition to future nanoparticles for Phase I and early Phase II studies conducted at the NIH Clinical Center. This acquisition is being conducted using policies unique to the Federal Acquisition Regulation (FAR) Part 13 �Simplified Acquisition Procedures, Subpart 13.106-1(b)(1), For purchases not exceeding the simplified acquisition...